Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role Podcast

By AHRMM

Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.

Related Resources

Guides/Reports
The UDI Impacts on Recall Management Work Group, a part of AHRMM's Learning UDI Community (LUC), has released their recommended practices reports…
Guides/Reports
As the health care industry is continuing to evolve, many industry leaders are looking to build a more resilient supply chain by asking, “What coul
Podcasts
Learn the best practices of setting PAR levels and what you need to know to ensure you have the proper stock.
White Papers
Healthcare expenses continue to rise and yet hospitals are realizing consistently shrinking margins.
e-Learning
Enhance your knowledge of health care supply chain management with our Introduction to Health Care Supply Chain course. Improve patient care and…
Letter/Comment
The AHRMM LUC members submitted public comments and recommendations at the FDA's November 2020 meeting related to the need to include the UDI in the…